MedPath

DIGOX

DIGOX (Digoxin Tablets, USP) 125 mcg (0.125 mg) 250 mcg (0.25 mg)

Approved
Approval ID

ba92b74c-3549-4ab8-8bfb-d0caa8e35af0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 15, 2012

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Digoxin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-1602
Application NumberANDA076268
Product Classification
M
Marketing Category
C73584
G
Generic Name
Digoxin
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 23, 2012
FDA Product Classification

INGREDIENTS (9)

DIGOXINActive
Quantity: 125 ug in 1 1
Code: 73K4184T59
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIGOX - FDA Drug Approval Details